BioHealth News Archive
BioFactura Awarded $1 Million SBIR Contract for Development of a Marburg Virus Therapeutic
FREDERICK, Md., July 29, 2020 /PRNewswire-PRWeb/ -- BioFactura, Inc. today announced a $1 million Small Business Innovation Research (SBIR) Phase II contract awarded by…
Read MoreJohns Hopkins Ranks 3rd In The Nation’s Best Hospitals List – CBS Baltimore
BALTIMORE (WJZ) — Johns Hopkins Hospital ranked no. 3 among the nation’s best hospitals, according to U.S. News & World Report. The Best Hospitals…
Read More
TEDCO Announces New Executives | Maryland | curated.tncontentexchange.com
COLUMBIA, Md., July 28, 2020 /PRNewswire/ -- TEDCO, Maryland's economic engine for technology companies, announced today the appointments of Michael Hauser as the Managing Director…
Read More
Biobuzz Directory – HemoShear Therapeutics Receives FDA Fast Track and Rare Pediatric Disease Designations for HST5040 to Treat Methylmalonic Acidemia and Propionic Acidemia
Charlottesville, Va., July 28, 2020 – HemoShear Therapeutics, a clinical stage company developing treatments for rare metabolic disorders, has received Fast Track and Rare Pediatric…
Read More
Opinion | Sputnik set off the Space Age. This virus can spark the Health Age. – The Washington Post
Regina E. Dugan is chief executive of Wellcome Leap, a nonprofit that seeks breakthroughs in human health. From 2009 to 2012, she served as…
Read More
Hopkins spinoff Thrive Earlier Detection Corp. raises $257 million funding round – Baltimore Business Journal
Johns Hopkins cancer diagnostics spinoff Thrive Earlier Detection Corp. has raised $257 million in new funding a little over a year after it closed…
Read More
American Gene Technologies (AGT) Moves HQ to New Facility, Expands Lab Space for HIV and Cancer Cure Research – Across From National Cancer Institute Campus | American Gene Technology
ROCKVILLE, Md., July 28, 2020 -- American Gene Technologies (AGT), an internationally recognized leading gene and cell therapy company in Rockville, Maryland, today announced…
Read More
SARS-CoV-2 Lurked for Decades Where Others Like It Lurk Still
Future pandemics—and suffering of the kind inflicted by COVID-19—could be avoided if we troubled ourselves to see where dangerous pathogens lie in wait. We…
Read More
Biotechnology draws $12.6B from private equity, venture capital activity in H1 | S&P Global Market Intelligence
Biotechnology led the healthcare industry in investment activity from private equity and venture capital during the first half of 2020, drawing nearly $12.60 billion…
Read MoreJohns Hopkins Receives $35M In Funding For COVID-19 Blood Plasma Trials – CBS Baltimore
BALTIMORE (WJZ) — Johns Hopkins researchers have received over $30 million in funding from the U.S. Department of Defense for two nationwide clinical trials to…
Read More
Innate Pharma announces publication of EXPLORE COVID-19 translational study findings in Nature | Innate Pharma
Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the publication of a Nature paper entitled,…
Read More
Illumina Accelerator Grant Competition
Now Accepting Rolling Grant Applications The Illumina Accelerator Sequencing Grant Competition encourages entrepreneurs to build startups using next-generation sequencing. Awarded grant winners have the…
Read More
SHYCOCAN – A Device to Disable Coronaviruses – to be Marketed Under US-FDA’s Enforcement Discretion During the COVID-19 Public Health Emergency | BioSpace
GAITHERSBURG, Md., July 23, 2020 /PRNewswire/ -- Shreis Scalene Therapeutics LLC (SSTx), a MD-USA-based medical device company will fast-track the manufacture and distribution of…
Read More
TruGenomix just won Start Up of the Year Pitch Event
Excited to announce that TruGenomix just won Start Up of the Year Pitch Event. Great pitch Charles Cathlin !!!!! #SDVOB #ptsd #TruGenomix #veteranshelpingveterans
Read More
Emergent Bio inks deal with AstraZeneca for manufacture of COVID-19 vaccine (NYSE:EBS) | Seeking Alpha
Emergent BioSolutions (NYSE:EBS) has signed an agreement with AstraZeneca (NYSE:AZN) to provide contract development and manufacturing (CDMO) services for large-scale drug substance manufacturing for AZN's…
Read More